Literature DB >> 33923629

Molecular Mechanisms of Atopic Dermatitis Pathogenesis.

Jowita Sroka-Tomaszewska1, Magdalena Trzeciak1.   

Abstract

Atopic dermatitis is a chronic, non-infectious inflammatory dermatosis. Acharacteristic feature is persistent itching of the skin. The chronic, relapsing course of the disease, economic burden, and the whole family's involvement in the treatment process immensely reduce the quality of life of patients and their families. The disease emerges as a social problem by increasing indirect costs, such as visiting a doctor, absenteeism from work and school, and avoiding social interactions. Thepathophysiology of atopic dermatitis is complex and multifactorial. It includes genetic disorders, a defect in the epidermal barrier, an altered immune response, anddisruption of the skin's microbial balance. The numerous complex changes at thegenetic level and innate and adaptive immunity provide the basis for characterizing the various phenotypes and endotypes of atopic dermatitis. Emerging therapies rely on the action of specific molecules involved in the disease's pathogenesis. It may be the starting point for the individualization of atopic dermatitis treatment. This paper will try to present some molecular mechanisms of atopic dermatitis and their clinical implications.

Entities:  

Keywords:  allergic diseases; atopic dermatitis; epidermal barriers defects; genetic disorders; immunological disturbances; microbiome; pathogenesis; targeted therapies

Year:  2021        PMID: 33923629     DOI: 10.3390/ijms22084130

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  15 in total

Review 1.  Where's the Beef? Understanding Allergic Responses to Red Meat in Alpha-Gal Syndrome.

Authors:  Audrey S Carson; Aliyah Gardner; Onyinye I Iweala
Journal:  J Immunol       Date:  2022-01-15       Impact factor: 5.422

Review 2.  Immunological Pathomechanisms of Spongiotic Dermatitis in Skin Lesions of Atopic Dermatitis.

Authors:  Ryoji Tanei; Yasuko Hasegawa
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

3.  The Difference of Gut Microbiota and Their Correlations With Urinary Organic Acids Between Autistic Children With and Without Atopic Dermatitis.

Authors:  Ru-Ping Hong; Yue-Ying Hou; Xin-Jie Xu; Ji-Dong Lang; Yun-Feng Jin; Xiao-Feng Zeng; Xuan Zhang; Geng Tian; Xin You
Journal:  Front Cell Infect Microbiol       Date:  2022-06-21       Impact factor: 6.073

Review 4.  Current and Emerging Therapies in Pediatric Atopic Dermatitis.

Authors:  Hadley Johnson; JiaDe Yu
Journal:  Dermatol Ther (Heidelb)       Date:  2022-10-18

Review 5.  Managing Atopic Dermatitis with Lebrikizumab - The Evidence to Date.

Authors:  Angelina Labib; Teresa Ju; Gil Yosipovitch
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-06-08

6.  Possible role of arginase 1 positive microglia on depressive/anxiety-like behaviors in atopic dermatitis mouse model.

Authors:  Bohyun Yang; Jae-Sang Ryu; Chan Rim; Jung U Shin; Min-Soo Kwon
Journal:  Arch Pharm Res       Date:  2022-01-20       Impact factor: 4.946

7.  Editorial of Special Issue "Molecular Mechanisms of Allergy and Asthma".

Authors:  Daniel P Potaczek
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

Review 8.  Aquaporins Are One of the Critical Factors in the Disruption of the Skin Barrier in Inflammatory Skin Diseases.

Authors:  Paola Maura Tricarico; Donatella Mentino; Aurora De Marco; Cecilia Del Vecchio; Sabino Garra; Gerardo Cazzato; Caterina Foti; Sergio Crovella; Giuseppe Calamita
Journal:  Int J Mol Sci       Date:  2022-04-05       Impact factor: 5.923

9.  1-Iodohexadecane Alleviates 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis in Mice: Possible Involvements of the Skin Barrier and Mast Cell SNARE Proteins.

Authors:  Do Yoon Kim; Kyung-Jong Won; Dae Il Hwang; Nan Young Kim; Bokyung Kim; Hwan Myung Lee
Journal:  Molecules       Date:  2022-02-25       Impact factor: 4.411

10.  Characterization and In Vitro and In Vivo Evaluation of Tacrolimus-Loaded Poly(ε-Caprolactone) Nanocapsules for the Management of Atopic Dermatitis.

Authors:  Guilherme Dos Anjos Camargo; Leandro Ferreira; Diego José Schebelski; Amanda Martinez Lyra; Fernanda Malaquias Barboza; Bruna Carletto; Adriana Yuriko Koga; Betina Christi Semianko; Daniele Toniolo Dias; Leandro Cavalcante Lipinski; Andressa Novatski; Vijayasankar Raman; Jane Manfron; Jessica Mendes Nadal; Paulo Vitor Farago
Journal:  Pharmaceutics       Date:  2021-11-26       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.